本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

144.88
+1.150.80%
盘前:144.80-0.0800-0.06%04:29 EDT
成交量:89.85万
成交额:1.31亿
市值:93.75亿
市盈率:140.66
高:152.19
开:145.83
低:143.69
收:143.73
52周最高:160.81
52周最低:73.08
股本:6,470.83万
流通股本:6,316.60万
量比:0.98
换手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
净资产收益率:10.98%
总资产收益率:4.55%
市净率:11.14
市盈率(LYR):-70.67

数据加载中...

2026/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities